Prostate cancer drug that can halve death risk to be offered to thousands in England
At least 6,000 men a year with hormone-sensitive cancer to get access to darolutamide, which blocks growth with fewer side-effects Thousands of men with advanced prostate cancer in England are to be offered a drug that can halve the risk of death. In guidance published on Friday, the National (…)
Site référencé:
The Guardian (South&CentralAsia)
3333.jpg?width=140&quality=85&auto=format&fit=max&s=4ef98f38f4c778416f19eff8a360aecc, 3333.jpg?width=460&quality=85&auto=format&fit=max&s=1150db78d91fedf560db661d7de6d353, 3333.jpg?width=700&quality=85&auto=format&fit=max&s=b88b50e1202d2797417341d7e43a97ab
The Guardian (South&CentralAsia)
Surge in UK savings lost to investment scams, with fake crypto thought to top the list
24/10/2025
Windrush victims to get 75% of compensation up front in scheme overhaul
24/10/2025
The Children’s Booker prize will tell kids that they matter
24/10/2025
Car production slumps to a 73-year low after JLR cyber-attack
24/10/2025
Premier League : 10 things to look out for this weekend
24/10/2025
EU leaders fail to agree to use frozen Russian assets to defend Ukraine
24/10/2025